APLS icon

Apellis Pharmaceuticals
APLS

Overview Fund Activity

300 hedge funds and large institutions have $6.65B invested in Apellis Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 105 increasing their positions, 90 reducing their positions, and 45 closing their positions.

Holders
300
Holders Change
+19
Holders Change %
+6.76%
% of All Funds
4.35%
Holding in Top 10
8
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-11.11%
% of All Funds
0.12%
New
66
Increased
105
Reduced
90
Closed
45
Calls
$111M
Puts
$94.7M
Net Calls
+$16.2M
Net Calls Change
-$230M

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$58.8M
2
Citadel Advisors
2
Citadel Advisors
Florida
$69.7M
3
Millennium Management
3
Millennium Management
New York
$46.2M
4
Deutsche Bank
4
Deutsche Bank
Germany
$94.7M
5
ITP
5
Iron Triangle Partners
Connecticut
$32.3M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$96.3M
2
T. Rowe Price Investment Management
2
T. Rowe Price Investment Management
Maryland
$271M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$885M
4
CM
4
Caption Management
Oklahoma
$1.82M
5
Macquarie Group
5
Macquarie Group
Australia
$13M
Name Market Value Shares Shares
Change 		Shares
Change %
Wellington Management Group
1
Wellington Management Group
Massachusetts
$885M 15,058,071 -1,387,219 -8%
EC
2
EcoR1 Capital
California
$668M 11,357,425 +184,357 +2%
ACA
3
Avoro Capital Advisors
New York
$653M 11,111,111 – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$559M 9,505,866 -49,812 -0.5%
BlackRock
5
BlackRock
New York
$323M 5,494,591 +113,338 +2%
T. Rowe Price Investment Management
6
T. Rowe Price Investment Management
Maryland
$271M 4,605,721 -1,697,863 -27%
Jennison Associates
7
Jennison Associates
New York
$190M 3,240,513 -35,409 -1%
State Street
8
State Street
Massachusetts
$171M 2,909,528 -5,894 -0.2%
OCA
9
Octagon Capital Advisors
New York
$165M 2,806,980 – –
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$145M 2,459,246 -1,093 -0%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$130M 2,214,309 -359,824 -14%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$128M 2,178,742 +86,278 +4%
Assenagon Asset Management
13
Assenagon Asset Management
Luxembourg
$119M 2,023,614 -121,390 -6%
BC
14
Boxer Capital
California
$101M 1,726,000 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$99.4M 1,689,890 +59,248 +4%
Morgan Stanley
16
Morgan Stanley
New York
$96.3M 1,637,618 -4,556,664 -74%
Deutsche Bank
17
Deutsche Bank
Germany
$94.7M 1,611,773 +754,774 +88%
AG
18
Artal Group
Luxembourg
$77.3M 1,315,282 -106,064 -7%
O
19
OrbiMed
New York
$76.3M 1,297,800 +375,600 +41%
Citadel Advisors
20
Citadel Advisors
Florida
$69.7M 1,186,082 +900,965 +316%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$63M 1,073,234 -271,329 -20%
PCH
22
Polar Capital Holdings
United Kingdom
$62M 1,054,440 +1,000 +0.1%
Norges Bank
23
Norges Bank
Norway
$59.2M 1,007,920 +61,707 +7%
DTC
24
Deep Track Capital
Connecticut
$58.8M 1,000,000 +1,000,000 New
Fiera Capital (Canada)
25
Fiera Capital (Canada)
Quebec, Canada
$55.7M 948,437 +29,347 +3%
1
2 3 4 5